📍 Simply passing a USP validation is no longer enough if your formulation is prone to LER. You must demonstrate recovery over the actual storage duration of the product. ### How to Implement TR 82 in Your Lab
Guidance on hold-time studies and masking/demasking strategies. ### Understanding Low Endotoxin Recovery (LER)
Citrate, phosphate, and EDTA often accelerate masking. pda technical report 82 pdf
Biopharmaceutical products containing polysorbates and buffers (e.g., citrate or phosphate).
Polysorbate 20 and 80 are the primary culprits. 📍 Simply passing a USP validation is no
If you are looking for the , it is available for purchase and download through the PDA Bookstore .
Ensuring patient safety through reliable bacterial endotoxin testing (BET). If you are looking for the , it
Identify products with "high-risk" ingredients (Surfactants + Chelators).
Do you need to know which trigger LER most? Are you preparing for a regulatory audit ?
Detailed protocols on how to spike samples and at what intervals to test them to ensure stability.